Proceedings: The effects of different doses of chenodeoxycholic acid and of withdrawing treatment on bile lipid composition and liver function in patients with gallstones.
D001219:Aspartate Aminotransferases / Q000097:blood; D001646:Bile / Q000032:analysis*; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage*; D002769:Cholelithiasis / Q000188:drug therapy* / Q000503:physiopathology; D002784:Cholesterol / Q000032:analysis; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000097:blood; D008055:Lipids / Q000032:analysis; D008099:Liver / Q000201:enzymology / Q000503:physiopathology*
D008055:Lipids; D002635:Chenodeoxycholic Acid; D002784:Cholesterol; D007521:Isocitrate Dehydrogenase; D001219:Aspartate Aminotransferases